Abcam plc EV - Enterprise Value 2011-2026 | ABCM

Annual EV - Enterprise Value Abcam plc

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
241 M	5.59 B	-22.4 M	-25.2 M	63.1 M	54.6 M	68.4 M	35.8 M	25.7 M	29.6 M	27.6 M	12.6 M

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
5.59 B	-25.2 M	508 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	849 M	$ 219.68	1.92 %	$ 5 B	Danmark
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Seres Therapeutics MCRB	412 M	$ 8.28	-	$ 1.06 B	USA
Amphastar Pharmaceuticals AMPH	1.92 B	$ 19.45	1.14 %	$ 909 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Mesoblast Limited MESO	1.4 B	$ 15.44	7.82 %	$ 10 B	Australia
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	169 M	$ 0.67	-5.25 %	$ 7.67 M	Israel
Mirum Pharmaceuticals MIRM	5.68 B	$ 90.39	2.86 %	$ 4.54 B	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	1.11 B	$ 1.34	1.52 %	$ 342 M	Britain
MediciNova MNOV	42.4 M	$ 1.45	-	$ 71.1 M	USA
CytomX Therapeutics CTMX	971 M	$ 4.37	2.95 %	$ 603 M	USA
Cyclacel Pharmaceuticals CYCC	8.71 M	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Aytu BioScience AYTU	-15.2 M	$ 2.69	1.37 %	$ 16.9 M	USA
Dynavax Technologies Corporation DVAX	2.02 B	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	145 M	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Merck & Co. MRK	296 B	$ 117.56	1.02 %	$ 294 B	USA
Marker Therapeutics MRKR	6.72 M	$ 1.37	8.73 %	$ 21 M	USA
Moderna MRNA	20.5 B	$ 53.09	3.41 %	$ 20.7 B	USA
Bellerophon Therapeutics BLPH	77.1 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	847 M	$ 4.47	3.71 %	$ 856 M	Canada
Homology Medicines FIXX	-28.5 M	-	0.77 %	$ 53.4 M	USA